The Minimum-Face VUL Inside an ILIT

The short answer. When someone offers to solve your trust’s dividend tax by wrapping the portfolio in a variable universal life policy, fix the trust instead of buying the wrapper. Draft the ILIT as a grantor trust, hold the index fund directly, and pay the trust’s income tax personally — that eliminates the drag the policy was sold to eliminate, and the tax you pay is itself a gift-tax-free transfer (section “Intentionally Defective Grantor Trusts (IDGTs)”). The wrapper costs money; the drafting choice is free.

The pitch, stated fairly. It is better than the usual cash-value sale, which is why it gets traction with people who know better. Assets you gift to a completed-gift irrevocable trust leave your estate, and with them goes the basis step-up under IRC §1014, “Basis of property acquired from a decedent” — Rev. Rul. 2023-2 confirmed that grantor trust status does not rescue it — so the trust’s index fund carries both an annual dividend tax and a permanent embedded gain your children inherit. A VUL funded to the statutory minimum death benefit under IRC §7702 holds the same index fund with no dividend tax, no embedded gain, and a death benefit that arrives income-tax-free under IRC §101(a)(1). If the policy’s charges come in under the tax drag they replace, the wrapper wins. A representative 2026 illustration — a 41-year-old male, preferred plus, $292,000 single premium, $592,840 specified amount, Cash Value Accumulation Test — charges a 6% premium load ($17,520 off the top), $1,752 a year in per-$1,000 face charges for ten years, $120 a year of administration, a COI that starts at $39, and a 0.24% sub-account against 0.03% for a retail total-market ETF. Against 1.3% in qualified dividends taxed at a combined 35% — a 0.455% annual drag — the arithmetic looks like it works.

Why the comparison is rigged. The illustration compares the policy to an index fund in a non-grantor trust. Nobody competent drafts one. Grantor trust status is a drafting choice, not a feature of either product: an ILIT whose income may be applied to premiums on the grantor’s life is already a grantor trust as to that income under IRC §677(a)(3), “Income for benefit of grantor”, and for a trust holding securities instead you retain a power to substitute assets of equivalent value under IRC §675(4)(C). Either way the trust pays no income tax, you do, and Rev. Rul. 2004-64 confirms that paying it is not a gift. The drag the wrapper was sold to eliminate does not exist in a properly drafted trust. Table 18.1 runs the same 8.5% gross assumption through all three.

Read the last two columns against the first two. The policy’s cash value does not overtake even the non-grantor portfolio until policy year 34, at age 75, and it never overtakes the grantor version at all. The death benefit — the number the illustration leads with — stays ahead of the grantor-trust portfolio only until policy year 42, at age 83, and falls $1.5 million behind by age 91. A preferred-plus 41-year-old male has a life expectancy in the mid-eighties. The product wins if you die roughly on schedule or early, and loses if you live, which is a peculiar thing to buy when the stated goal is compounding for your children.

The inversion nobody mentions. If your estate is over the exemption, income tax inside a grantor trust is a feature. Every dollar of tax you pay on the trust’s earnings is a dollar that leaves your estate at no gift-tax cost and would otherwise have been taxed at 40%. Over forty years the 0.455% drag on this portfolio costs about $390,000 in personal income tax — and moves that $390,000 out of a taxable estate, saving roughly $156,000 of estate tax on top of the compounding uplift. The IRC §7702 wrapper eliminates the income tax, and in doing so eliminates your best estate-freeze lever. You are paying an insurance company to take away a benefit.

Where the pitch is actually right. Two criteria must hold together: first, you are far enough over the exemption that you have no room to use the substitution power late in life to swap high-basis assets into the trust and pull the appreciated position back into your estate for a step-up (section “Optimizing for Basis in the High-Exemption Era”) — that swap is the standard answer to the embedded-gain problem, and it works until you run out of exemption. Second, your heirs will actually liquidate instead of holding, so the embedded gain is a real liability, not a deferred one. When both hold, a IRC §7702 wrapper does genuine work — and the correct wrapper is Private Placement Life Insurance at institutional pricing with no commission (section “Private Placement Life Insurance (PPLI)”) instead of a retail policy that hands $17,520 to the carrier before a dollar is invested. Below the roughly $3–5 million premium that makes PPLI viable, the bottom line is that the tax being solved for is not large enough to be worth a seventy-nine-year contract.

What the illustration will not tell you.

Almost none of it is guaranteed.

The current-charge column is a projection. The carrier holds a unilateral option to raise the premium load (6% current, 10% guaranteed), the percent-of-sub-account charge (0% current, 0.50% guaranteed), and the COI toward its guaranteed maximum — typically room to triple. You hold no offsetting option except a IRC §1035 exchange that depends on your still being insurable. Carriers have exercised that option and been sued for it; Palumbo v. Nationwide (D. Conn. No. 3:16-cv-1143, settled 2018) is the name people cite, and it is not the only one. You sold a valuable option for nothing.

The “tax equivalent IRR” column is marketing.

It divides the policy’s internal rate of return by one minus an assumed ordinary tax rate — 30% in the input summary of the illustration above — to produce a headline like 11.58%. That is the return a fully ordinary-income-taxed alternative would need. Nobody’s alternative is that. The comparison you care about is the cash-value IRR against a qualified-dividend index fund, and the illustration reports both if you read past the number in bold.

The COI eventually exceeds the drag it replaced.

On this illustration the cost of insurance runs 0.26% of cash value at age 81, 0.56% at 91, and 0.65% at 94 — past the 0.455% dividend drag the policy was sold to avoid, at ages the buyer is most likely to reach. The 0.40% persistency credit that starts in year 16 is what keeps the late-year math afloat.

Straight-line returns hide the real risk.

Charges are denominated in dollars and in net amount at risk, not a percentage of a falling account. A bad sequence raises the amount at risk exactly when the cash value is down, so the policy sells more shares at the bottom — negative convexity a constant-8.5% projection cannot show. Run the 0% column: under current charges this policy lapses at age 90 despite $292,000 paid in, and under guaranteed charges at 71.

It is a MEC from day one.

A single premium against a $41,867 seven-pay limit makes the contract a modified endowment under IRC §7702A immediately. Harmless if the policy is never touched, which is the plan — but it means no loans and no withdrawals for seventy-nine years without ordinary income treatment. Every liquidity option is gone.

Somebody has to run it for seven decades.

Crummey notices, gift tax returns, premium administration, lapse monitoring, and a re-illustration every year — through your own cognitive decline and past your death. The index fund in the same trust requires none of it. Complexity that outlives your competence to manage it is a cost, and it is the one the illustration is structurally incapable of pricing.